lars fruergaard jorgensen - Search News

News

Novo Nordisk, weight and Lars Fruergaard

CBS News on MSN · 1d

Novo Nordisk CEO Lars Jorgensen, who led company into weight loss drugs, to step down

Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual agreement."

Medical Dialogues · 1h

Lars Fruergaard Jorgensen to step down as CEO of Novo Nordisk

Denmark: Novo Nordisk has announced that Lars Fruergaard Jorgensen will step down from his role as CEO of Novo Nordisk. He will continue as CEO for a period to support a smooth transition to

The Wall Street Journal on MSN · 1d

Ozempic Drugmaker’s CEO Pushed Out Amid Weight-Loss Market Challenges

Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to support a smooth transition to new leadership.

1d

Ozempic-Maker CEO Ousted Over Pharma Company’s Rocky Market Downturn

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the ...

1d

Novo CEO’s Shock Exit: Who Will Take Over Obesity Drug Giant?

Novo Nordisk A/S’s surprise decision to replace Chief Executive Officer Lars Fruergaard Jorgensen has triggered a race to ...

BioPharma Dive1d

Novo CEO to depart as obesity drugmaker’s challenges rise

Lars Fruergaard Jørgensen will step down after eight years helming the Danish drugmaker, shares of which have shed half their ...

Changing Guard at Novo Nordisk: Navigating Stormy Waters in Obesity Drug Market

Novo Nordisk has replaced CEO Lars Fruergaard Jorgensen amid competitive pressures in the obesity drug market. His exit comes ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results